71 / 100

Dr.Navdeep Dehar | Oncology | Excellence in Research

Medical Oncologist Queens University Canada

Navdeep Dehar MBBS MD MBT FRCPC is an Assistant Professor in the Department of Oncology at Queen’s University and a Clinician Investigator & Medical Oncologist at the Cancer Centre of Southeastern Ontario. Additionally, he serves as a Precision Medicine Research Fellow at the Canadian Cancer Trials Group. With extensive training and experience in oncology, pharmacology, and biomedical technology, Dr. Dehar has made significant contributions to cancer research and clinical practice.

Profile

Scopus

Education

🎓 Education:

  • Subspecialty Training in Medical Oncology (2021-2023) – Queen’s University, Kingston, ON
  • Residency in Internal Medicine (2018-2021) – Cumming School of Medicine, University of Calgary, Alberta
  • Master of Biomedical Technology (MBT) (2012-2013) – University of Calgary, Alberta
  • Residency in Pharmacology – Doctor of Medicine (MD) (2005-2008) – Baba Farid University of Health Sciences, India
  • Bachelor of Medicine and Bachelor of Surgery (MBBS) (1998-2002) – Dayanand Medical College and Hospital, Baba Farid University of Health Sciences, India

Experience

💼 Experience:

  • Clinician Investigator & Staff Medical Oncologist (Locum) (July 2023 – present) – Cancer Centre of Southeastern Ontario, Kingston, ON
  • Assistant Professor of Medical Oncology (July 2023 – present) – Department of Medical Oncology, Queen’s University, Kingston, ON
  • Precision Medicine Research Fellow (October 2023 to September 2024) – Canadian Clinical Trials Group (CCTG), Kingston, ON
  • Medical Oncology Resident (2021-2023) – Queen’s University, Kingston, ON
  • Internal Medicine Resident (2018-2021) – University of Calgary, AB
  • Clinical Research Consultant (2013-2018) – GNR Biomedical Inc.

Research Interests

🔬 Research Interests:

  • Gastrointestinal Cancers
  • Neuroendocrine Tumors
  • Breast Cancer
  • Precision Oncology
  • Artificial Intelligence/Machine Learning in Oncology
  • Quality Improvement in Clinical Trials
  • Cancer Therapeutics with a Focus on Pharmacogenomics
  • Patient and Physician Education Initiatives
  • Global Oncology with a Focus on Quality Improvement

Awards

🏆 Awards:

  • Scholarship for Training in Lung Cancer (2023) – Canadian Lung Cancer Conference, Vancouver
  • Award of Appreciation for Extraordinary Contribution to Resident Redeployment Initiative during COVID Pandemic (2022) – Queen’s University, Kingston
  • Dr. Chirag Shah International Medical Graduate Award Recipient (2018) – Alberta International Medical Graduate Program, University of Calgary
  • Young Scientist Award (2008) – Sant Longowal Institute of Science and Technology, India

Publications

📚 Publications:

  • Dehar N, Gupta A, Singh G. “Comparative Study of the Efficacy and Safety of Ketorolac Tromethamine 0.5% Ophthalmic Solution and Diclofenac Sodium 0.1% Ophthalmic Solution in Patients of Acute Seasonal Allergic Conjunctivitis.” Int J Appl Basic Med Res. 2012 Jan-Jun; 2(1): 25–30. doi:10.4103/2229-516X.96799
  • Miriam Mutebi, Navdeep Dehar, Leticia M. Nogueira, Kewei Shi, K. Robin Yabroff,
    and Bishal Gyawali. Cancer Groundshot: Building a Robust Cancer Control Platform in
    Addition To Launching the Cancer Moonshot. American Society of Clinical Oncology
    Educational Book 2022:42, 1-16
Navdeep Dehar | Oncology | Excellence in Research

You May Also Like